The Effects of Mindfulness‐Based Programs on Pain‐Related Cognitions in Individuals With Chronic Musculoskeletal Pain: A Systematic Review and Meta‐Analysis
Pain Research and Management · 2026-01 · 2026 (1)
DOI: 10.1155/prm/6495015 ↗Abstract
Objectives Chronic musculoskeletal pain is a complex condition influenced by psychological factors, including pain‐related cognitions. This systematic review and meta‐analysis of randomized controlled trials aimed to evaluate the effects of mindfulness‐based programs on pain‐related cognitions in individuals with chronic musculoskeletal pain. Secondary outcomes included depression, anxiety, psychological distress, pain intensity, disability, intervention adherence, and mindfulness‐related adverse events. Methods Eight databases were searched from inception to January 2026. Evidence was synthesized using random‐effects models and reported as standardized mean differences with 95% confidence intervals. Risk of bias was assessed using the revised Cochrane risk of bias tool. Evidence certainty was rated using GRADE. Results Fifty‐one studies ( n = 5997) were included and had a moderate‐to‐high risk of bias. Compared to no intervention, mindfulness‐based programs reduced pain catastrophizing (SMD: 1.00, 95% CI: 0.56–1.45) and increased pain acceptance (SMD: 1.12, 95% CI: 0.31–1.92) post‐intervention. They also reduced depression (SMD: 0.94, 95% CI: 0.50–1.38), anxiety (SMD: 1.08, 95% CI: 0.57–1.59), psychological distress (SMD: 0.75, 95% CI: 0.12–1.38), pain intensity (SMD: 0.80, 95% CI: 0.38–1.23), and disability (SMD: 0.48, 95% CI: 0.04–0.92) compared to no intervention. Minimal significant differences were observed between the effect of mindfulness‐based programs and cognitive behavioral therapy on these outcomes. Discussion Mindfulness‐based programs appear to be an effective self‐management strategy for individuals with chronic musculoskeletal pain. However, the certainty of evidence is mostly low with intervention adherence varying. Future research should clarify the direction and nature of the relationship between adherence and outcomes. Reporting of mindfulness‐related adverse events was insufficient to evaluate safety; future trials should incorporate comprehensive measurement.
EUVIMED